Progress of Immunotherapy and Its Application in Triple Negative Breast Cancer
In recent years, potential new therapeutic options have been yielded for the immunotherapy of invasive cancers. The most important breakthrough in breast cancer research today is to understand the immune features and profiles of triple negative breast cancer and then design novel immune-modulatory t...
Main Authors: | ZHENG Hongmei, FENG Yaojun, XU Juan, CHENG Hongtao, JIN Liting, ZHONG Wei, WU Xinhong |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2020-11-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2020.20.0332.htm |
Similar Items
-
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
by: Alyssa Vito, et al.
Published: (2021-05-01) -
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
by: Karan Mediratta, et al.
Published: (2020-11-01) -
Recent advances in triple negative breast cancer: the immunotherapy era
by: Antonio Marra, et al.
Published: (2019-05-01) -
Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01) -
Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
by: Shaoquan Zheng, et al.
Published: (2020-11-01)